Start

On Aug. 31, the FDA approved first-time generic formulations of 30, 60, and 180 mg fexofenadine HCl tablets (made by Barr Laboratories, Inc.; brand name Allegra, made by Aventis Pharmaceuticals, Inc.).

Fexofenadine tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children aged six years and older. Symptoms treated effectively in clinical studies included sneezing, rhinorrhea, itchy nose/palate/throat, and itchy/watery/red eyes.

Fexofenadine is also indicated for the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged six years and older. In clinical studies, fexofenadine significantly reduced pruritus and number of wheals.

End

This entry was posted on Tuesday, July 1st, 2008 at 5:14 am and is filed under General Information. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.